4017711000001108: Lanreotide acetate (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

14670501000001118 Lanreotide acetate (substance) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

14670601000001119 Lanreotide acetate en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Lanreotide acetate	Is a	Lanreotide	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Lanreotide 60mg/0.3ml solution for injection pre-filled syringes	Has active ingredient	False	Lanreotide acetate	Inferred relationship	Existential restriction modifier
Lanreotide 90mg/0.3ml solution for injection pre-filled syringes	Has active ingredient	False	Lanreotide acetate	Inferred relationship	Existential restriction modifier
Lanreotide 120mg/0.5ml solution for injection pre-filled syringes	Has active ingredient	False	Lanreotide acetate	Inferred relationship	Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials	Has active ingredient	False	Lanreotide acetate	Inferred relationship	Existential restriction modifier
Somatuline Autogel 60mg/0.3ml solution for injection pre-filled syringes (Ipsen Ltd)	Has active ingredient	False	Lanreotide acetate	Inferred relationship	Existential restriction modifier
Somatuline Autogel 90mg/0.3ml solution for injection pre-filled syringes (Ipsen Ltd)	Has active ingredient	False	Lanreotide acetate	Inferred relationship	Existential restriction modifier
Somatuline Autogel 120mg/0.5ml solution for injection pre-filled syringes (Ipsen Ltd)	Has active ingredient	False	Lanreotide acetate	Inferred relationship	Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd)	Has active ingredient	False	Lanreotide acetate	Inferred relationship	Existential restriction modifier
Lanreotide 60mg/0.3ml solution for injection pre-filled syringes 1 pre-filled disposable injection	Has active ingredient	False	Lanreotide acetate	Inferred relationship	Existential restriction modifier
Lanreotide 90mg/0.3ml solution for injection pre-filled syringes 1 pre-filled disposable injection	Has active ingredient	False	Lanreotide acetate	Inferred relationship	Existential restriction modifier
Lanreotide 120mg/0.5ml solution for injection pre-filled syringes 1 pre-filled disposable injection	Has active ingredient	False	Lanreotide acetate	Inferred relationship	Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial	Has active ingredient	False	Lanreotide acetate	Inferred relationship	Existential restriction modifier
Somatuline Autogel 60mg/0.3ml solution for injection pre-filled syringes (Ipsen Ltd) 1 pre-filled disposable injection	Has active ingredient	False	Lanreotide acetate	Inferred relationship	Existential restriction modifier
Somatuline Autogel 90mg/0.3ml solution for injection pre-filled syringes (Ipsen Ltd) 1 pre-filled disposable injection	Has active ingredient	False	Lanreotide acetate	Inferred relationship	Existential restriction modifier
Somatuline Autogel 120mg/0.5ml solution for injection pre-filled syringes (Ipsen Ltd) 1 pre-filled disposable injection	Has active ingredient	False	Lanreotide acetate	Inferred relationship	Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial	Has active ingredient	False	Lanreotide acetate	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets